Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCvc Ig Eur Regulatory News (CVCE)

Share Price Information for Cvc Ig Eur (CVCE)

Share Price is delayed by 15 minutes
Get Live Data
1.055    0.00 (0.00%)
Bid:
1.05
Ask:
1.07
Spread: 0.02 (1.905%)
Market Cap: €292.81m
CVCE Live PriceLast checked at - London Stock Exchange

Intraday Cvc Ig Eur Share Chart

Total Voting Rights

15 May 2026 14:44

RNS Number : 5793E
CVC Income & Growth Limited
15 May 2026
 

15 May 2026

 

CVC Income & Growth Limited

(the Company)

 

Total Voting Rights

 

 

Further to the completion of the March 2026 Contractual Semi-Annual Tender today and pursuant to Rule 5.6.1A(1) of the FCA's Disclosure Guidance and Transparency Rules, the Company notifies the market of the following:

 

As at 12pm on 15 May 2026, the Company's issued share capital (excluding treasury shares) consisted of:

 

· 193,255,993 ordinary Sterling shares of no par value; and

· 83,790,791 ordinary Euro shares of no par value.

 

Each ordinary Sterling share carries the right to 1.17 votes, and each ordinary Euro share carries the right to 1 vote.

 

The total number of voting rights of the ordinary Sterling shares of no par value is 226,109,511 and of the ordinary Euro shares of no par value is 83,790,791.

 

The total number of voting rights in the Company is therefore 309,900,302.

 

The Company holds the following ordinary shares in treasury:

 

· 178,753,766 ordinary Sterling shares of no par value (non-voting); and

· 58,309,884 ordinary Euro shares of no par value (non-voting).

 

The above figure, 309,900,302, may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Enquiries:

BNP Paribas S.A., Jersey Branch

Company Secretary

 cvccpeolcosec@bnpparibas.com

 

 

 

Cadarn Capital

Distribution and Investor Relations

 

Telephone: +44 20 7019 9042

 info@cadarncapital.com

 

 

Winterflood Securities

Broker

 

Telephone: +44 0203 100 0000

 

 Neil Morgan - Corporate Finance

 Innes Urquhart - Corporate Sales

 Darren Willis - Corporate Sales

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRGPUPCAUPQGWA
Date   Source Headline
29th Jan 20253:13 pmRNSIssue of Equity
27th Jan 20256:15 pmRNSDIVIDEND DECLARATION & DIV TARGET '25(Replacement)
27th Jan 20257:00 amRNSJANUARY 2025 SHARE CONVERSION
24th Jan 20255:25 pmRNSMONTHLY REPORT
24th Jan 20252:30 pmRNSNet Asset Value Weekly to 17 Jan 2025
24th Jan 202512:53 pmRNSDividend Declaration & Annual Dividend target '25
22nd Jan 20255:08 pmRNSIssue of Equity
22nd Jan 20254:00 pmRNSIssue of Equity
21st Jan 20255:09 pmRNSNet Asset Value Month End 31 Dec 2024
17th Jan 20254:25 pmRNSNet Asset Value Weekly to 10 Jan 2025
17th Jan 20253:58 pmRNSIssue of Equity
16th Jan 20251:05 pmRNSIssue of Equity
15th Jan 20254:24 pmRNSIssue of Equity
14th Jan 20254:37 pmRNSIssue of Equity
10th Jan 20254:47 pmRNSHolding(s) in Company
10th Jan 20254:31 pmRNSIssue of Equity
9th Jan 20255:10 pmRNSNet Asset Value Weekly to 03 Jan 2025
9th Jan 20254:44 pmRNSIssue of Equity
8th Jan 20255:00 pmRNSIssue of Equity
7th Jan 20259:09 amRNSMarch 2025 Semi Annual Tender Restrictions
2nd Jan 20255:10 pmRNSNet Asset Value Weekly to 27 Dec 2024
30th Dec 20241:20 pmRNSNet Asset Value Weekly to 20 Dec 2024
20th Dec 20248:54 amRNSMonthly Report
19th Dec 20245:05 pmRNSNet Asset Value Weekly to 13 Dec 2024
18th Dec 202412:09 pmRNSNet Asset Value Month End 29 Nov 2024
17th Dec 20242:42 pmRNSJANUARY 2025 SHARE CONVERSION
12th Dec 20242:29 pmRNSNet Asset Value Weekly to 06 Dec 2024
5th Dec 202412:10 pmRNSNet Asset Value Weekly to 29 Nov 2024
2nd Dec 20249:49 amRNSTotal Voting Rights
28th Nov 20243:30 pmRNSNet Asset Value Weekly to 22 Nov 2024
22nd Nov 20244:26 pmRNSMonthly Report
22nd Nov 20244:25 pmRNSHolding(s) in Company
22nd Nov 20244:10 pmRNSMonthly Report
20th Nov 20245:10 pmRNSNet Asset Value Weekly to 15 Nov 2024
19th Nov 20249:48 amRNSNet Asset Value Month End 31 Oct 2024
15th Nov 20245:00 pmRNSTotal Voting Rights
14th Nov 20245:45 pmRNSNet Asset Value Weekly to 08 Nov 2024
12th Nov 20242:06 pmRNSDirector/PDMR Shareholding
7th Nov 20242:45 pmRNSNet Asset Value Weekly to 01 Nov 2024
31st Oct 20245:00 pmRNSNet Asset Value Weekly to 25 Oct 2024
31st Oct 20247:00 amRNSSeptember 2024 Tender – Purchase of shares
25th Oct 20247:00 amRNSDividend Declaration
24th Oct 20243:40 pmRNSNet Asset Value Weekly to 18 Oct 2024
21st Oct 20249:36 amRNSSeptember 2024 Tender Price (replacement)
21st Oct 20247:00 amRNSSeptember 2024 Tender Price
18th Oct 20244:34 pmRNSMonthly Report
17th Oct 20245:50 pmRNSNet Asset Value Weekly to 11 Oct 2024
15th Oct 202412:43 pmRNSNet Asset Value Month End 30 Sep 2024
10th Oct 20245:00 pmRNSNet Asset Value Weekly to 04 Oct 2024
4th Oct 20241:50 pmRNSNet Asset Value Weekly to 27 Sep 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.